Article ID Journal Published Year Pages File Type
2023003 Regulatory Peptides 2009 6 Pages PDF
Abstract

Urotensin II (UII) is a somatostatin-like peptide recently identified to be involved in metabolic regulation and to play a significant role in diabetes and its complications. In the present study, we investigated the expression of UII and its receptor UT in the soleus muscle of male diabetic KK/upj-AY/J mice (2DM group) and the effects of UII on glucose uptake by the skeletal muscle to explore the role of skeletal muscle-derived UII in the pathogenesis of insulin resistance and diabetes. Radioimmunoassay, RT-PCR, immunohistochemistry and radio-ligand binding assay were used in this study. Compared with C57BL/6J mice (control group), 2DM mice showed increased UII content, by 34.0% in plasma, 15.4% in skeletal muscle tissue and 30.6% in medium containing UII from muscle (all P < 0.05 or P < 0.01). UII protein and UT mRNA expression were significantly enhanced in the skeletal muscle of 2DM mice. On [125I]UII binding to muscle sarcolemma, UT binding exhibited a saturable single-component characteristic in a specific and time-dependent manner. Scatchard plot analysis showed higher maximal number of specific binding sites (Bmax) in skeletal muscle, by 42.9% (P < 0.01), and a lower dissociation constant (Kd), by 26.4% (P < 0.01), in the 2DM group than in controls. On in vitro tissue pre-incubation with UII (10− 9, 10− 8 and 10− 7 mol/L), the insulin-stimulated [3H]-2-DG uptake by split soleus muscle was lower, by 9.5%, 33.4% and 39.7% (all P < 0.01), respectively, than without UII incubation. UII/UT upregulated in skeletal muscle of 2DM mice suggests that UII derived from skeletal muscle might induce the pathogenesis of skeletal muscle insulin resistance as an autocrine factor.

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Authors
, , , , , , , ,